ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization

Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., Hanna, M. A., Hazenberg, B. P. C., Kristen, A. V., Kwong, R. Y., Maurer, M. S., Merlini, G., Miller, E. J., Moon, J. C., Murthy, V. L., Quarta, C. C., Rapezzi, C., Ruberg, F. L., Shah, S. J., Slart, R. H. J. A., Verberne, H. J. & Bourque, J. M., 9-Aug-2019, In : JOURNAL OF CARDIAC FAILURE.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard


  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization

    Proof, 2 MB, PDF-document

    Request copy


  • Sharmila Dorbala
  • Yukio Ando
  • Sabahat Bokhari
  • Angela Dispenzieri
  • Rodney H Falk
  • Victor A Ferrari
  • Marianna Fontana
  • Olivier Gheysens
  • Julian D Gillmore
  • Andor W J M Glaudemans
  • Mazen A Hanna
  • Bouke P C Hazenberg
  • Arnt V Kristen
  • Raymond Y Kwong
  • Mathew S Maurer
  • Giampaolo Merlini
  • Edward J Miller
  • James C Moon
  • Venkatesh L Murthy
  • C Cristina Quarta
  • Claudio Rapezzi
  • Frederick L Ruberg
  • Sanjiv J Shah
  • Riemer H J A Slart
  • Hein J Verberne
  • Jamieson M Bourque

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Original languageEnglish
Publication statusE-pub ahead of print - 9-Aug-2019

View graph of relations

ID: 95758864